Pacific Biosciences of California Inc.
02/03/2026 | Press release | Distributed by Public on 02/03/2026 15:21
Management Change/Compensation (Form 8-K)
ITEM 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
On February 3, 2026, Pacific Biosciences of California, Inc. (the "Company") announced that, effective January 28, 2026, Mark Van Oene, the Company's Chief Operating Officer, will on an interim basis assume responsibilities for the Company's sales and customer support organizations, which were previously assigned to Christian Henry, the Company's President & Chief Executive Officer. Mr. Henry will on an interim basis assume responsibilities for the Company's operations and research and development organizations, which were previously assigned to Mr. Van Oene. Both Mr. Henry and Mr. Van Oene will retain their other core responsibilities, and there will be no change to the title or compensation of Mr. Henry or Mr. Van Oene as a result of the foregoing.
Pacific Biosciences of California Inc. published this content on February 03, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 03, 2026 at 21:21 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]